Shuichi Nakagawa

Senior Manager Facilities Operation Japan Asia at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Shuichi Nakagawa's Colleagues at Alnylam Pharmaceuticals
Denise Spinning

Business Account Executive

Contact Denise Spinning

Jennifer Tarkka

Business Account Executive

Contact Jennifer Tarkka

Lynn Dohnalek

Manager, Regulatory Affairs

Contact Lynn Dohnalek

David Konys

VP, Corporate Development & Operations

Contact David Konys

Rena Denoncourt

Vice President, TTR Franchise Lead

Contact Rena Denoncourt

View All Shuichi Nakagawa's Colleagues
Shuichi Nakagawa's Contact Details
HQ
(617) 551-8200
Location
Tokyo,Japan
Company
Alnylam Pharmaceuticals
Shuichi Nakagawa's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Shuichi Nakagawa
Shuichi Nakagawa currently works for Alnylam Pharmaceuticals.
Shuichi Nakagawa's role at Alnylam Pharmaceuticals is Senior Manager Facilities Operation Japan Asia.
Shuichi Nakagawa's email address is ***@alnylam.com. To view Shuichi Nakagawa's full email address, please signup to ConnectPlex.
Shuichi Nakagawa works in the SaaS industry.
Shuichi Nakagawa's colleagues at Alnylam Pharmaceuticals are Denise Spinning, Jennifer Tarkka, Lynn Dohnalek, Jordyn Trapilo, David Konys, Rena Denoncourt, Stephen Babigian and others.
Shuichi Nakagawa's phone number is (617) 551-8200
See more information about Shuichi Nakagawa